製薬 ・ クエスタ・カンポスは、知的財産権、（情報技術とデータ保護）、規制、外国貿易、労働、取引の各分野の専門家で構成されたチームを擁しており、クライアントに包括的なサービスを提供しています。
・ 当事務所は、ライフサイエンス、製薬、医療機器、診断分野のユニークで複雑なニーズに豊富な経験を有しており、クライアントのビジネスパートナーとして、日々の業務のあらゆる段階、あらゆる側面において、費用対効果の高い法務コンサルティングサービスを提供しています。
・ 当事務所では、商標登録、発明特許、衛生登録、ライセンス・提携契約、表示規制、広告、知的財産権訴訟、労働問題、関係当局への働きかけ、さらには国際貿易プロセス、契約などを取り扱っています。
Representation of a leading pharmaceutical company of Dutch origin in a complex patent litigation related to the following:
• Amparo before District and Circuit Courts in relation to the marketing authorization.
• Litigation for patent infringement before the Mexican Institute of Industrial Property (IMPI).
• Litigation of nullity of patent before the Mexican Institute of the Industrial Property (IMPI).
Representation and legal advice in the development and implementation of the brand protection strategy in Mexico and in twelve countries in Latin America for a renowned American pharmaceutical company. Cuesta Campos was in charge of the coordination of all brand registrations in the different jurisdictions.
Growth of a leading pharmaceutical company in Mexico and Latin America. Our firm carried out the urbanization of properties, including consultation and legal support in relation to the declaration of urban land, negotiation of the donation of areas for cession in favor of the municipality, compliance with environmental laws, land use reports, certificates of alignment and official number, building licenses, operating licenses, as well as other permits required for the operation of the pharmaceutical company.
Representation, advise and management of the company’s brand portfolio specialized in baby products in more than 50 countries. Cuesta Campos also assisted this client in the preparation and application of the distribution agreements in countries that have a valuable commercial strategy.
Cuesta Campos analyzed the electronic platform used by distributors and consultants of a worldwide leading company in the manufacture of beauty and personal care products, to ensure the fulfillment of the legal requirements in terms of privacy, confidentiality, data and business protection, including the acceptance of terms and policies, as well as the authentication of electronic signatures.